Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Indaba Capital Management, L.P.

Q2 2024 · 13F-HR

Indaba Capital Management, L.P.holdings as filed

Filed 2024-08-14 · accession 0001011438-24-000459

$154.9M
Reported value
7
Positions
2024-06-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
294628102HP5AEQUITY COMWLTH$52.4M33.8%2,700,000CommonSOLE
05988JAD5BAND 0.5 04/01/28BANDWIDTH INC$37.0M23.9%49,250,000CommonSOLE
68339B104ONTFON24 INC$25.5M16.5%4,240,256CommonSOLE
09239B109BLBLACKLINE INC$14.1M9.13%292,000CommonSOLE
98423FAB5XMTR 1 02/01/27XOMETRY INC$13.4M8.63%17,750,000CommonSOLE
00430HAC6ACCELERATE DIAGNOSTICS INC$11.6M7.49%24,083,901CommonSOLE
29664WAB1ESPR 4 11/15/25ESPERION THERAPEUTICS INC NE$926,3000.60%1,000,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.